Core Viewpoint - Nanox Imaging Ltd is set to report its financial results for Q2 2025 on August 12, 2025, with a conference call scheduled for 8:30 a.m. ET to discuss these results and provide a business update [1]. Company Overview - Nanox is focused on advancing preventive healthcare through affordable medical imaging technologies that utilize advanced AI and proprietary digital X-ray sources [3]. - The company's vision includes expanding its technology's reach beyond hospital settings, offering a comprehensive solution from scanning to diagnosis, and leveraging AI for improved diagnostic accuracy [4]. Product and Service Ecosystem - Nanox.ARC: A multi-source digital tomosynthesis system that is cost-effective and user-friendly [4]. - Nanox.AI LTD: A subsidiary that provides AI-based algorithms to enhance routine CT imaging readings, focusing on early signs of chronic diseases [4]. - Nanox.CLOUD: A cloud-based platform for managing data from Nanox devices, offering tools for detailed imaging analysis [4]. - Nanox.MARKETPLACE: A decentralized marketplace through USARAD Holdings Inc. that provides remote access to radiology and cardiology experts, along with a teleradiology services platform [4].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Apple Inc. for alleged misrepresentations regarding the impact of advanced AI-based Siri features on iPhone 16 sales [3][4]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Northern District of California on behalf of investors who purchased Apple securities between June 10, 2024, and June 9, 2025 [3]. - Allegations include violations of the Securities Exchange Act of 1934 by Apple and certain senior officers [3]. - The lawsuit claims that the defendants made misrepresentations concerning damages to iPhone 16 sales due to integration time for new AI features [4]. Group 2: Participation Information - Investors wishing to serve as lead plaintiffs must file necessary documents by August 19, 2025 [5]. - Serving as a lead plaintiff allows representation of other class members in directing the litigation, but participation in any recovery does not require this role [5]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [6].